Compare AMLX & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMLX | CTOS |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2022 | N/A |
| Metric | AMLX | CTOS |
|---|---|---|
| Price | $12.33 | $5.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $17.43 | $7.33 |
| AVG Volume (30 Days) | ★ 1.4M | 715.3K |
| Earning Date | 11-06-2025 | 10-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,936,513,000.00 |
| Revenue This Year | N/A | $13.19 |
| Revenue Next Year | N/A | $4.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.39 |
| 52 Week Low | $2.60 | $3.18 |
| 52 Week High | $16.96 | $6.78 |
| Indicator | AMLX | CTOS |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 46.44 |
| Support Level | $11.69 | $5.89 |
| Resistance Level | $12.80 | $6.10 |
| Average True Range (ATR) | 0.67 | 0.23 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 21.53 | 54.17 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.